thiotepa has been researched along with Liver Dysfunction in 3 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simon, N | 1 |
| Coiteux, V | 1 |
| Bruno, B | 1 |
| Taque, S | 1 |
| Charbonnier, A | 1 |
| Souchet, L | 1 |
| Vincent, L | 1 |
| Yakoub-Agha, I | 1 |
| Chalandon, Y | 1 |
| Lee, JL | 1 |
| Gooley, T | 1 |
| Bensinger, W | 1 |
| Schiffman, K | 1 |
| McDonald, GB | 1 |
| O'Dea, MJ | 1 |
| Malek, RS | 1 |
| Farrow, GM | 1 |
1 review available for thiotepa and Liver Dysfunction
| Article | Year |
|---|---|
[Dose adaptation of the drugs used for hematopoietic stem-cell transplantation in patients with comorbidity: Obesity, chronic renal disease or hepatopathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-T
Topics: Adult; Age Factors; Busulfan; Child; Comorbidity; Cyclophosphamide; Etoposide; France; Hematopoietic | 2017 |
1 trial available for thiotepa and Liver Dysfunction
| Article | Year |
|---|---|
Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Busulfan; Child; Child, Preschool; Cyclo | 1999 |
1 other study available for thiotepa and Liver Dysfunction
| Article | Year |
|---|---|
Malacoplakia of the urinary tract: challenges and frustations with 10 cases.
Topics: Adult; Aged; Ammonium Chloride; Anti-Bacterial Agents; Electrocoagulation; Female; Humans; Liver Dis | 1977 |